Inovio Pharmaceuticals, Inc.INONASDAQ
Loading
Revenue ContractionContracting
Percentile Rank0
3Y CAGR-81.5%
5Y CAGR-61.2%
Studio
Year-over-Year Change

Total revenue from sales of goods and services

3Y CAGR
-81.5%/yr
vs -23.8%/yr prior
5Y CAGR
-61.2%/yr
Recent deceleration
Acceleration
-57.6pp
Decelerating
Percentile
P0
Near historical low
vs 5Y Ago
0x
Contraction
Streak
3 yr
Consecutive declineContracting
PeriodValueYoY Change
2025$65343.00-70.0%
2024$217756.00-73.8%
2023$832010.00-91.9%
2022$10.26M+478.2%
2021$1.77M-76.1%
2020$7.41M+80.2%
2019$4.11M-86.5%
2018$30.48M-27.8%
2017$42.22M+19.4%
2016$35.37M-